Karla A. Henning - 1Bolt Biotherapeutics

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 26 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

821 the Combination of a Trastuzumab ISAC and Pertuzumab Augments Anti-Tumor Efficacy in Multiple HER2+ Tumor Models Relative to Trastuzumab Plus Pertuzumab

Edith A Perez,Andrew Luo,Anthony Lucas,Han K Kim, Paul D Ponath, Katelynn A McEachin,Karla A Henning,Shelley E Ackerman,Steven J Chapin,Michael N Alonso,Cecelia I Pearson, David Omstead

Regular and Young Investigator Award Abstracts (2023)

引用0浏览0引用

Targeting Tumor-Associated Macrophages to Enhance Anti-Tumor Immunity with the Dectin-2 Agonistic Antibody BDC-3042

Justin A. Kenkel, Fang Xiao,Po Y. Ho,Jess L. Nolin, Rishali K. Gadkari, Laughing Bear Torrez, David T. Omstead, Katelynn A. McEachin,Jason Ptacek, Rachel Grgich,Cecelia I. Pearson, Stefan Chun,Cindy L. Kreder,Karla A. Henning,Han K. Kim,Lu Xu,Steven J. Chapin,Michael N. Alonso,Shelley E. Ackerman

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

Abstract 2964: Targeting Tumor-Associated Macrophages to Enhance Anti-Tumor Immunity with the Dectin-2 Agonistic Antibody BDC-3042

Justin A. Kenkel,Fang Xiao,Po Y. Ho,Jess L. Nolin, Rishali K. Gadkari, Laughing Bear Torrez, David T. Omstead, Katelynn A. McEachin,Jason Ptacek, Rachel Grgich,Cecelia I. Pearson, Stefan Chun,Cindy L. Kreder,Karla A. Henning,Han K. Kim,Lu Xu,Steven J. Chapin,Michael N. Alonso,Shelley E. Ackerman

Cancer Researchno. 7_Supplement (2023): 2964-2964

引用0浏览0引用

Supplementary Figures 1 - 4 from Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity Through Reduction of Intratumoral Regulatory T Cells

Mark J. Selby,John J. Engelhardt, Michael Quigley,Karla A. Henning,Timothy Chen,Mohan Srinivasan, Alan J. Korman

openalex（2023）

引用0浏览0引用

1147-D Preclinical Characterization of a Novel Claudin 18.2 Targeting-Isac with Robust Potency and Acceptable Safety Profile

Matthew Zhou,William Mallet,Romas Kudirka,Han K Kim, Justin Monnier, Chi-Ling Fu,Jennifer E Melrose, Hung Dao, Paul D Ponath, Katelynn A McEachin, David T Omstead,Cindy Kreder, Stefan Chun, Ying Yueh Lee, Rachel Grgich, Tracey J Lin, Joshua A Walker,Karla A Henning,Shelley E Ackerman, Diane Carrera,Steven J Chapin,Dowdy Jackson, Changshou Gao,Michael N Alonso

Journal for ImmunoTherapy of Cancerno. Suppl 2 (2023)

引用0浏览0引用

1348 BDC-3042: A Dectin-2 Agonistic Antibody for Tumor-Associated Macrophage-Directed Immunotherapy

Justin Kenkel,Rishali Gadkari,Jess Nolin, Fang Xiao,Po Ho,Cindy Kreder, Laughing Bear Torrez, David Omstead,Katelynn McEachin,Jason Ptacek, Lu Xu, Duy Nguyen,Karla Henning,Steven Chapin,David Dornan,Michael Alonso,Shelley Ackerman

Regular and Young Investigator Award Abstracts (2022)

引用0浏览0引用

Abstract 2883: Dectin-2 Agonist Antibodies Reprogram Tumor-Associated Macrophages to Drive Anti-Tumor Immunity

Justin A. Kenkel,Po Y. Ho,Karla A. Henning,Cindy L. Kreder,Jess L. Nolin,Sameera Kongara,Steven J. Chapin,Amreen Husain,Marcin Kowanetz,Edgar G. Engleman,Michael N. Alonso,David Dornan,Shelley E. Ackerman

Cancer researchno. 12_Supplement (2022): 2883-2883

引用0浏览0引用

Dectin-2 agonist antibodies reprogram tumor-associated macrophages to drive anti-tumor immunity

CANCER RESEARCH（2022）

引用0浏览0引用

862 Dectin-2, a Novel Target for Tumor Macrophage Reprogramming in Cancer Immunotherapy

Justin Kenkel,Po Ho,Sameera Kongara,Karla Henning,Cindy Kreder,Jess Nolin,Steven Chapin,Marcin Kowanetz,Michael Alonso,Shelley Ackerman,Edgar Engleman,David Dornan

Regular and Young Investigator Award Abstractsno. Suppl 2 (2021): A903-A903

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn